These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 34339678)

  • 21. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Methylations on N6-Adenine and N6-Adenosine with the same Input but Different Output.
    Li Z; Zhao P; Xia Q
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the epitranscriptomic role of N
    Ogbe SE; Wang J; Shi Y; Wang Y; Xu Z; Abankwa JK; Dal Pozzo L; Zhao S; Zhou H; Peng Y; Chu X; Wang X; Bian Y
    Biomed Pharmacother; 2024 Aug; 177():117041. PubMed ID: 38964182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential roles of RNA N6-methyladenosine in atherosclerosis.
    Chen LH; Zhao YY; Huang L; Li YZ; Xu HQ; Yang C; Zhang C
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1075-1083. PubMed ID: 35253196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of N6-methyladenosine with viruses and virally induced diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1184-1201. PubMed ID: 32114429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of m6A RNA methylation in cancer.
    Sun T; Wu R; Ming L
    Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dynamic reversible RNA N
    Bi Z; Liu Y; Zhao Y; Yao Y; Wu R; Liu Q; Wang Y; Wang X
    J Cell Physiol; 2019 Jun; 234(6):7948-7956. PubMed ID: 30644095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of m6A RNA methylation in cardiovascular disease (Review).
    Qin Y; Li L; Luo E; Hou J; Yan G; Wang D; Qiao Y; Tang C
    Int J Mol Med; 2020 Dec; 46(6):1958-1972. PubMed ID: 33125109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the N
    Scarrow M; Chen N; Sun G
    Crit Rev Biotechnol; 2020 Aug; 40(5):639-652. PubMed ID: 32321323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-methyladenosine and Neurological Diseases.
    Zhang N; Ding C; Zuo Y; Peng Y; Zuo L
    Mol Neurobiol; 2022 Mar; 59(3):1925-1937. PubMed ID: 35032318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N6-methyladenosine links RNA metabolism to cancer progression.
    Dai D; Wang H; Zhu L; Jin H; Wang X
    Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases.
    Tan M; Liu S; Liu L
    Clin Epigenetics; 2024 Sep; 16(1):127. PubMed ID: 39261973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of m6A methylation in retinal diseases.
    Zhu X; Zhou C; Zhao S; Zheng Z
    Exp Eye Res; 2023 Jun; 231():109489. PubMed ID: 37084873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
    Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
    Front Oncol; 2022; 12():927640. PubMed ID: 35936737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.